Andere Sprachen PT Kalbe Farma Tbk.

Aktien

KLBF

ID1000125107

KLBF

Schlusskurs INDONESIA S.E. Andere Börsenplätze 00:00:00 24.04.2024			% 5 Tage	% 1. Jan.
1’405 ^IDR	-1.40%		-3.44%	-12.73%

01.04.	PT Kalbe Farma Tbk. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
20.02.	PT KALBE FARMA TBK. : Nomura bekräftigt seine Kaufempfehlung	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023	01.04.
PT Kalbe Farma Tbk. Reports Earnings Results for the Nine Months Ended September 30, 2023	31.10.23
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)	23.10.23
Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius novel anti-PD-1 mAb HANSIZHUANG in MENA	13.09.23
PT Kalbe Farma Tbk : KIMIA FARMA & KALBE FARMA COLLABORATED TO IMPROVE HEALTH SERVICES FOR THE SOCIETY	01.09.23
PT Kalbe Farma Tbk. Reports Earnings Results for the Half Year Ended June 30, 2023	07.08.23
PT Kalbe Farma Tbk : KALBE INTRODUCES MESOTHERAPY PRODUCTS IN AESTHETIC TREATMENT	17.07.23
PT Kalbe Farma Tbk : KALBE INTRODUCES AUTOIMMUNE DISEASES FURTHER	08.07.23
PT Kalbe Farma Tbk : Kalbe Announced Dividend of 52% from Net Profit	04.05.23
PT Kalbe Farma Tbk : 2022, Recover Together for Healthier Nation	02.05.23
PT Kalbe Farma Tbk : Kalbe Maintained Double Digit Top Line Growth in the First Quarter of 2023	28.04.23
PT Kalbe Farma Tbk : Company Update - Q1 2023 Unaudited Results (28-April-2023)	28.04.23
PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2023	28.04.23
PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2022	28.03.23
PT Kalbe Farma Tbk : THE INAUGURATION OF THE KALBE UBAYA HANBANG-BIO LABORATORY PILOT PLANT, SUPPORTING THE INDEPENDENCE OF NATIONAL INGREDIENTS	02.03.23
Progen Co. Ltd. announced that it has received IDR 155.72 billion in funding from PT Kalbe Farma Tbk.	02.01.23
PT Kalbe Farma Tbk. Reports Earnings Results for the Nine Months Ended September 30, 2022	31.10.22
PT Kalbe Farma Tbk. completed the acquisition of a 80% stake in PT Aventis Pharma from Hoechst GmbH and Sanofi-Aventis Participations S.A.S.	26.10.22
PT Kalbe Farma Tbk : KALBE BEGINS STEPS TO BUILD CLEAN WATER ACCESS IN WONOGIRI	10.10.22
PT Kalbe Farma Tbk : SUPPORTING THE SDGs, KALBE PROVIDED ACCESS TO CLEAN WATER FOR THE PEOPLE IN WONOGIRI	22.09.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen PT Kalbe Farma Tbk.

Aktien

KLBF

ID1000125107

KLBF

Andere Sprachen

Filter